Ovarian function and adjuvant chemotherapy for early breast cancer
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (6) , 745-748
- https://doi.org/10.1016/0277-5379(87)90272-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Serum prolactin levels in women with breast cancer and their relationship to survivalEuropean Journal of Cancer and Clinical Oncology, 1986
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCERThe Lancet, 1984
- ADJUVANT CHEMOTHERAPY IN BREAST CANCERThe Lancet, 1983
- Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patientsCancer, 1983
- Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breastBreast Cancer Research and Treatment, 1983
- Plasma and urinary androgens in women with varying degrees of risk of breast cancerPublished by Elsevier ,1979
- OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCERThe Lancet, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- XVII-Some non-parametric tests.BMJ, 1976
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976